awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q57216049-4E6426D9-5C84-446B-B93B-D4E57445C606
Q57216049-4E6426D9-5C84-446B-B93B-D4E57445C606
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57216049-4E6426D9-5C84-446B-B93B-D4E57445C606
Identifying a Clinically Applicable Mutational Burden Threshold as a Potential Biomarker of Response to Immune Checkpoint Therapy in Solid Tumors
P2860
Q57216049-4E6426D9-5C84-446B-B93B-D4E57445C606
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57216049-4E6426D9-5C84-446B-B93B-D4E57445C606
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
89490917e735674aedececb27183d9fc8bc461fb
P2860
Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study.